PL435831A1 - Sucha kompozycja do rozpuszczania w wodzie - Google Patents

Sucha kompozycja do rozpuszczania w wodzie

Info

Publication number
PL435831A1
PL435831A1 PL435831A PL43583120A PL435831A1 PL 435831 A1 PL435831 A1 PL 435831A1 PL 435831 A PL435831 A PL 435831A PL 43583120 A PL43583120 A PL 43583120A PL 435831 A1 PL435831 A1 PL 435831A1
Authority
PL
Poland
Prior art keywords
water
solube
dry composition
composition
mosm
Prior art date
Application number
PL435831A
Other languages
English (en)
Other versions
PL243659B1 (pl
Inventor
Jacek Klocek
Tomasz Ledwon
Original Assignee
Biogliko Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogliko Spółka Z Ograniczoną Odpowiedzialnością filed Critical Biogliko Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL435831A priority Critical patent/PL243659B1/pl
Priority to EP20209795.2A priority patent/EP3991720A1/en
Publication of PL435831A1 publication Critical patent/PL435831A1/pl
Publication of PL243659B1 publication Critical patent/PL243659B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/09—Lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Przedmiotem wynalazku jest sucha kompozycja do rozpuszczania w wodzie zawierająca środek osmotyczny, charakteryzująca się tym, że zawiera glukozę, co najmniej jeden alkohol cukrowy oraz co najmniej jeden czynnik powlekający błonę śluzową do zastosowania we wspomaganiu organizmu pacjenta przygotowującego się do badań endoskopowych, przy czym po rozpuszczeniu w wodzie roztwór wodny kompozycji jest klarownym roztworem o osmolarności > 170 mOsm/L.
PL435831A 2020-10-30 2020-10-30 Sucha kompozycja do rozpuszczania w wodzie PL243659B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL435831A PL243659B1 (pl) 2020-10-30 2020-10-30 Sucha kompozycja do rozpuszczania w wodzie
EP20209795.2A EP3991720A1 (en) 2020-10-30 2020-11-25 Dry composition for dissolving in water

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL435831A PL243659B1 (pl) 2020-10-30 2020-10-30 Sucha kompozycja do rozpuszczania w wodzie

Publications (2)

Publication Number Publication Date
PL435831A1 true PL435831A1 (pl) 2022-05-02
PL243659B1 PL243659B1 (pl) 2023-09-25

Family

ID=74175555

Family Applications (1)

Application Number Title Priority Date Filing Date
PL435831A PL243659B1 (pl) 2020-10-30 2020-10-30 Sucha kompozycja do rozpuszczania w wodzie

Country Status (2)

Country Link
EP (1) EP3991720A1 (pl)
PL (1) PL243659B1 (pl)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150123A (en) 1977-11-21 1979-04-17 Wladyslaw Szturma Method for treating gastro intestinal ulcers with extract of herb cetraria
PL220812A1 (pl) 1979-12-27 1981-07-24 Stocznia Gdanska Im
FR2616327B3 (fr) 1987-06-10 1989-09-29 Pharmachim So Melange de plantes medicinales a titre de medicament pour le traitement des ulceres et des gastrites chroniques
GB0224909D0 (en) 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
US7332184B2 (en) * 2003-03-28 2008-02-19 Queen's University At Kingston Colonic cleansing composition and method
DE102009016119A1 (de) 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
EP2438077B1 (en) * 2009-06-03 2013-12-04 Aptalis Pharma U.S. Inc. L-sugar colon cleansing agent and uses thereof
BR112013019360A2 (pt) * 2011-01-28 2017-03-28 A Shaver William ingredientes, componente seco de formulação oral de baixo teor de cloreto farmaceuticamente aceitável para limpeza de cólon, solução de base de reposição de eletrólito aquosa para uso em lavagem colônica, métodos para limpar os intestinos de paciente, para preparar solução aquosa para limpeza do cólon e para aumentar substancialmente o paladar de limpador de cólon e kits para evacuação do cólon.
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
US20140255371A1 (en) 2013-03-08 2014-09-11 Cognate3 Llc Physical Optimization Beverage
US20180318234A1 (en) 2015-06-22 2018-11-08 Ctc Bio, Inc. Purgative composition for cleansing intestinal tract

Also Published As

Publication number Publication date
PL243659B1 (pl) 2023-09-25
EP3991720A1 (en) 2022-05-04

Similar Documents

Publication Publication Date Title
US12576096B2 (en) Topical, isotonic compositions for genital use
ES2301189T3 (es) Agentes de limpieza antimicrobianos.
CA2995549C (en) Map product and use thereof for inhibiting mucosal inflammations
JP6759335B2 (ja) カルボキシメチルキトサンスポンジ配合物
das Neves et al. Performance of an in vitro mucoadhesion testing method for vaginal semisolids: Influence of different testing conditions and instrumental parameters
BRPI0109078B1 (pt) composição antimicrobiana e contraceptiva que reduz o risco de transmissão ou infecção por doença sexualmente transmitida através de atividade sexual
CO5560532A2 (es) Pelicula para refrescar el aliento
Tuğcu-demiröz Development of in situ poloxamer-chitosan hydrogels for vaginal drug delivery of benzydamine hydrochloride: Textural, mucoadhesive and in vitro release properties
BR112013013351B1 (pt) composições tópicas para preservação ou restauração da integridade das mucosas
Ahmad et al. Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections
BRPI0411705B1 (pt) Uso de uma composição
PL435831A1 (pl) Sucha kompozycja do rozpuszczania w wodzie
Shrivastava et al. Clinical efficacy of a dual action, topical anti-edematous and antiinflammatory device for the treatment of external hemorrhoids
JP7635277B2 (ja) ラムダ－カラギーナンを含む個人用潤滑剤
BE1018740A3 (nl) Samenstelling voor de behandeling van vochtige epitheliale oppervlakken.
WO2011112166A1 (en) Method of treatment
US4665096A (en) Contraceptive methods and compositions
Wheeler A new Peripatus from Mexico
Tamilselvan et al. Demonstration of bronchial tree in sheep with silicone resin cast
RU2645074C2 (ru) Антиспаечное средство
CN104884070B (zh) 盐和糖的混合物在制备用于治疗哺乳动物的阴道松弛综合征或阴道干燥疾病的药物中的用途
US20260076922A1 (en) Decreasing acinetobacter populations in the microbiome
EA021632B1 (ru) Не содержащий глицерин осмотический слабительный суппозиторий и способ его получения
US20240180956A1 (en) A vaginal contraceptive composition for reinforcement of the cervical mucus barrier properties
RU2197231C2 (ru) Антибактериальное средство для лечения кожных заболеваний